Article Versions Notes

Tramonti A, Cuyàs E, Encinar JA, Pietzke M, Paone A, Verdura S, Arbusà A, Martin-Castillo B, Giardina G, Joven J, et al. Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2. Cancers. 2021; 13(16):4009. https://doi.org/10.3390/cancers13164009

Tramonti, Angela, Elisabet Cuyàs, José Antonio Encinar, Matthias Pietzke, Alessio Paone, Sara Verdura, Aina Arbusà, Begoña Martin-Castillo, Giorgio Giardina, Jorge Joven, and et al. 2021. "Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2" Cancers 13, no. 16: 4009. https://doi.org/10.3390/cancers13164009

Tramonti, A., Cuyàs, E., Encinar, J. A., Pietzke, M., Paone, A., Verdura, S., Arbusà, A., Martin-Castillo, B., Giardina, G., Joven, J., Vazquez, A., Contestabile, R., Cutruzzolà, F., & Menendez, J. A. (2021). Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2. Cancers, 13(16), 4009. https://doi.org/10.3390/cancers13164009